【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Relapsed Acute Myeloid Leukemia Overview 9
Therapeutics Development 10
Pipeline Products for Relapsed Acute Myeloid Leukemia – Overview 10
Pipeline Products for Relapsed Acute Myeloid Leukemia – Comparative Analysis 11
Relapsed Acute Myeloid Leukemia – Therapeutics under Development by Companies 12
Relapsed Acute Myeloid Leukemia – Therapeutics under Investigation by Universities/Institutes 17
Relapsed Acute Myeloid Leukemia – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Relapsed Acute Myeloid Leukemia – Products under Development by Companies 21
Relapsed Acute Myeloid Leukemia – Products under Investigation by Universities/Institutes 25
Relapsed Acute Myeloid Leukemia – Companies Involved in Therapeutics Development 26
4SC AG 26
AbbVie Inc. 27
Actinium Pharmaceuticals, Inc. 28
Agios Pharmaceuticals, Inc. 29
Amgen Inc. 30
Array BioPharma Inc. 31
Astellas Pharma Inc. 32
Astex Pharmaceuticals, Inc. 33
AstraZeneca PLC 34
AVEO Pharmaceuticals, Inc. 35
Boehringer Ingelheim GmbH 36
Bristol-Myers Squibb Company 37
Calithera Biosciences, Inc. 38
Celgene Corporation 39
Conkwest, Inc. 40
Cornerstone Pharmaceuticals, Inc. 41
CTI BioPharma Corp. 42
Daiichi Sankyo Company, Limited 43
Eisai Co., Ltd. 44
EpiZyme, Inc. 45
Exelixis, Inc. 46
F. Hoffmann-La Roche Ltd. 47
Fujifilm Corporation 48
GlaxoSmithKline plc 49
Igenica Biotherapeutics, Inc. 50
Incyte Corporation 51
Jiangsu Hansoh Pharmaceutical Co., Ltd. 52
JW Pharmaceutical Corporation 53
Karyopharm Therapeutics, Inc. 54
Kyowa Hakko Kirin Co., Ltd. 55
Les Laboratoires Servier SAS 56
MacroGenics, Inc. 57
Merck & Co., Inc. 58
Millennium Pharmaceuticals, Inc. 59
Novartis AG 60
Oxford BioTherapeutics Ltd 61
Plexxikon Inc. 62
Polaris Pharmaceuticals, Inc. 63
Seattle Genetics, Inc. 64
Sunesis Pharmaceuticals, Inc. 65
Synta Pharmaceuticals Corp. 66
Tolero Pharmaceuticals, Inc. 67
Verastem, Inc. 68
Relapsed Acute Myeloid Leukemia – Therapeutics Assessment 69
Assessment by Monotherapy Products 69
Assessment by Combination Products 70
Assessment by Target 71
Assessment by Mechanism of Action 75
Assessment by Route of Administration 78
Assessment by Molecule Type 80
Drug Profiles 82
4SC-202 – Drug Profile 82
AG-120 – Drug Profile 84
AG-221 – Drug Profile 86
alvocidib hydrochloride – Drug Profile 89
AMG-232 – Drug Profile 90
AT-9283 – Drug Profile 91
BI-836858 – Drug Profile 93
binimetinib – Drug Profile 94
bortezomib – Drug Profile 99
brentuximab vedotin – Drug Profile 104
cabozantinib s-malate – Drug Profile 109
cafusertib hydrochloride – Drug Profile 112
CB-839 – Drug Profile 113
Cell Therapy to Target CD123 for Relapsed and Refractory Acute Myeloid Leukemia – Drug Profile 114
Cell Therapy to Target CD33 for Acute Myeloid Leukemia – Drug Profile 115
Cell Therapy to Target Tumor Associated Antigen for Hematopoietic Malignancies – Drug Profile 116
CPI-613 – Drug Profile 117
crenolanib besylate – Drug Profile 119
CST-101 – Drug Profile 121
CWP-291 – Drug Profile 123
DFP-10917 – Drug Profile 125
DS-3032 – Drug Profile 126
elesclomol – Drug Profile 127
EPZ-5676 – Drug Profile 129
erlotinib hydrochloride – Drug Profile 131
FF-10501 – Drug Profile 134
ficlatuzumab – Drug Profile 135
FLX-925 – Drug Profile 137
gilteritinib fumarate – Drug Profile 138
GO-2032c – Drug Profile 139
GSK-2879552 – Drug Profile 140
GSK-525762 – Drug Profile 141
huCART19 – Drug Profile 142
IGN-523 – Drug Profile 143
ilorasertib – Drug Profile 144
imatinib mesylate – Drug Profile 146
indisulam – Drug Profile 148
Iomab-B – Drug Profile 149
KHK-2823 – Drug Profile 151
lenalidomide – Drug Profile 152
LGH-447 – Drug Profile 156
MGD-006 – Drug Profile 157
MK-2206 – Drug Profile 158
OX-001 – Drug Profile 161
pegargiminase – Drug Profile 162
PLX-3397 – Drug Profile 165
quizartinib dihydrochloride – Drug Profile 167
RG-7775 – Drug Profile 170
ruxolitinib phosphate – Drug Profile 171
S-055746 – Drug Profile 176
selinexor – Drug Profile 177
selumetinib sulfate – Drug Profile 181
Small Molecules to Inhibit MDM2 for Oncology – Drug Profile 184
TAK-659 – Drug Profile 185
TEN-010 – Drug Profile 186
tigecycline – Drug Profile 187
tosedostat – Drug Profile 188
trametinib dimethyl sulfoxide + uprosertib – Drug Profile 190
ulocuplumab – Drug Profile 192
venetoclax – Drug Profile 194
vorinostat – Drug Profile 197
vosaroxin – Drug Profile 201
VS-4718 – Drug Profile 203
Relapsed Acute Myeloid Leukemia – Recent Pipeline Updates 204
Relapsed Acute Myeloid Leukemia – Dormant Projects 316
Relapsed Acute Myeloid Leukemia – Discontinued Products 317
Relapsed Acute Myeloid Leukemia – Product Development Milestones 318
Featured News & Press Releases 318
Appendix 326
Methodology 326
Coverage 326
Secondary Research 326
Primary Research 326
Expert Panel Validation 326
Contact Us 326
Disclaimer 327
【レポート販売概要】
■ タイトル：再発性急性骨髄性白血病(Relapsed Acute Myeloid Leukemia)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015
■ 発行日：2015年3月19日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6250IDB
■ 調査対象地域：グローバル
- 世界主要国における大腸癌治療薬市場Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics Summary GBI Research, the leading business intelligence provider, has released its latest research, “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-d …
- Monopile Foundation: Dominance in Offshore Wind Foundation IndustryMonopile Foundation: Dominance in Offshore Wind Foundation Industry Summary The global offshore wind power industry has grown rapidly in recent years. Countries looking to increase their dependency on wind energy are increasingly looking to offshore wind projects due to high capacity factors and high wind speeds. On the other hand, the increased distance from the shore also increases the water dep …
- German Hospital Clinical Chemistry and Immunodiagnostics Market 2014This new report from Venture Planning Group contains 523 pages, 64 tables, and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with sign …
- 産業用バイオマスボイラーの世界市場2016-2020About Industrial Biomass Boilers Industrial biomass boilers are sometimes called bio boilers. The boilers primarily use wood chips or wood pellets as they are both efficient and sustainable when compared with traditional boilers that primarily use fossil fuels such as oil, coal, and gas. These boilers can cover the heating and power generation requirements of an entire building or a network of bui …
- ガラス製ミラーの世界市場The expansion of the global glass mirror industry is forecast to reach 5.1% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 9.7%. Currently, vehicle rear-view mirrors account for 50.4% of the global demand while the remaining market share is divided between framed glass mirrors (31.2%) and unframed glass mirrors (18.4%). China, Germany, Turkey, …
- 半導体CVD（化学気相成長）装置の世界市場2016-2020Covering: This industry research report includes a detailed segmentation of the global semiconductor CVD equipment market by product type (AP CVD, DP CVD, LP CVD, and MO CVD) and by end user (foundry, memory, and IDM). It also outlines the market shares for key regions such as APAC, Europe, and North America. The key vendors analyzed in this report are Applied Materials, Lam Research, Tokyo Electr …
- 2014年戦略提言：イギリスの病院止血診断検査市場This new report from Venture Planning Group contains 402 pages, 28 tables, and presents a comprehensive analysis of the UK hospital hemostasis diagnostic testing market, including: Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. V …
- ガラス食器の世界市場The expansion of the global kitchen and table glassware industry is forecast to reach 3.1% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 7.1%. Currently, other than lead crystal drinking glasses account for 47.4% of the global demand while the remaining market share is divided between lead crystal drinking glasses (2.6%), other lead crystal g …
- 免疫組織化学の世界市場予測（～2021）：抗体、試薬、キット、スライド染色装置、組織マイクロアレイThe immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing …
- 世界のビフェントリン市場2015The Global Bifenthrin Industry Report 2015 is a professional and in-depth study on the current state of the Bifenthrin industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Bifenthrin market analysis is provided for the international markets including development trends, competitive landscape analysis, a …
- アメリカの手術ナビゲーションシステム市場2016-2020About Surgical Navigation SystemsSurgical navigation system enhances computer-assisted surgeries by providing image guidance, navigation software, and computational equipment for both preoperative and intraoperative planning and guidance. The primary clinical aim of computer-assisted surgeries is to assist the surgeon in planning and implementing an optimal strategy of surgery, for diagnostic as w …
- 収穫モニタリング装置及びサービスの世界市場：流量センサー、土壌センサー、GPS/GNSSデバイス、ディスプレイ、ガイダンス及びステアリング等Yield monitoring devices and services allow farmers to assess effects of weather, soil properties, fertilizers, and pesticides on the yield production. For the past decade, due to the advent of innovative technologies, yield from agricultural practices has steadily increased and is helping growers to increase their profitability. The emergence of Internet of Things (IoT) and innovative data collec …
- LTE以後自己管理ネットワーク（SON）の課題と市場機会（Self Organizing Networks (SON) Challenges and Market Opportunities for LTE and beyond, Third Edition）The Fourth Generation (4G) of cellular communications based on the Long Term Evolution (LTE) standard promises much great network capacity. This greater supply of bandwidth will stimulate the development, implementation and operation of many new applications, each with very unique quality of service, bandwidth, and performance needs. It will be a much more complex network and this will facilitate …
- 薬剤溶出ステントのグローバル製品パイプライン動向2015Drug Eluting Stents (DES) - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Drug Eluting Stents (DES) - Pipeline Review, 2015" provides an overview of Drug Eluting Stents currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major p …
- Mitsui O.S.K. Lines, Ltd.：石油・ガスバリューチェーン分析レポート2013Mitsui O.S.K. Lines, Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Mitsui O.S.K. Lines, Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Mitsui O.S.K. Lines, Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. …
